Teleflex Incorporated (NYSE:TFX) Shares Sold by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC trimmed its position in Teleflex Incorporated (NYSE:TFX – Free Report) by 6.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,376 shares of the medical technology company’s stock after selling 282 shares during the period. Commonwealth Equity [...]

featured-image

Commonwealth Equity Services LLC trimmed its position in Teleflex Incorporated ( NYSE:TFX – Free Report ) by 6.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,376 shares of the medical technology company’s stock after selling 282 shares during the period.

Commonwealth Equity Services LLC’s holdings in Teleflex were worth $920,000 at the end of the most recent reporting period. Several other institutional investors also recently bought and sold shares of the company. Hantz Financial Services Inc.



acquired a new stake in Teleflex in the 2nd quarter worth about $252,000. iA Global Asset Management Inc. boosted its holdings in Teleflex by 3.

6% in the 2nd quarter. iA Global Asset Management Inc. now owns 3,249 shares of the medical technology company’s stock worth $683,000 after buying an additional 113 shares during the last quarter.

BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its holdings in Teleflex by 621.

3% in the 2nd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A.

now owns 30,698 shares of the medical technology company’s stock worth $6,457,000 after buying an additional 26,442 shares during the last quarter. Crossmark Global Holdings Inc. boosted its holdings in Teleflex by 1.

9% in the 2nd quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company’s stock worth $584,000 after buying an additional 53 shares during the last quarter.

Finally, Speece Thorson Capital Group Inc. boosted its holdings in Teleflex by 33.0% in the 2nd quarter.

Speece Thorson Capital Group Inc. now owns 48,046 shares of the medical technology company’s stock worth $10,106,000 after buying an additional 11,925 shares during the last quarter. 95.

62% of the stock is currently owned by institutional investors and hedge funds. Teleflex Stock Down 1.8 % TFX stock opened at $241.

50 on Wednesday. The firm has a market cap of $11.38 billion, a PE ratio of 38.

76, a PEG ratio of 2.20 and a beta of 1.16.

The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 2.

58. The firm’s 50 day moving average price is $234.07 and its 200-day moving average price is $220.

08. Teleflex Incorporated has a one year low of $177.63 and a one year high of $257.

85. Teleflex Announces Dividend The company also recently announced a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Thursday, August 15th were given a $0.

34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.

56%. The ex-dividend date of this dividend was Thursday, August 15th. Teleflex’s payout ratio is 21.

83%. Wall Street Analyst Weigh In TFX has been the topic of a number of research reports. Royal Bank of Canada raised their target price on shares of Teleflex from $235.

00 to $260.00 and gave the stock an “outperform” rating in a research note on Friday, August 2nd. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $205.

00 to $245.00 in a research note on Monday, July 1st. Truist Financial raised their target price on shares of Teleflex from $240.

00 to $247.00 and gave the stock a “hold” rating in a research note on Monday, August 5th. Finally, Stephens raised their target price on shares of Teleflex from $275.

00 to $290.00 and gave the stock an “overweight” rating in a research note on Friday, August 2nd. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock.

Based on data from MarketBeat, Teleflex presently has a consensus rating of “Moderate Buy” and an average target price of $265.57. Read Our Latest Stock Report on TFX Insider Buying and Selling at Teleflex In other Teleflex news, Director Stuart A.

Randle sold 2,674 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.

82. Following the sale, the director now owns 5,496 shares of the company’s stock, valued at $1,313,159.28.

The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website . 1.43% of the stock is owned by corporate insiders.

Teleflex Company Profile ( Free Report ) Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. See Also Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.

com to get the latest 13F filings and insider trades for Teleflex Incorporated ( NYSE:TFX – Free Report ). Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter .

.